Holen Sie sich die Stockscreener-App
1.57
0.63%
-0.01
Handel nachbörslich:
1.58
0.01
+0.64%
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Caribou Biosciences (NASDAQ:CRBU) Price Target Cut to $5.00 by Analysts at Bank of America - MarketBeat
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView
Caribou Biosciences earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Caribou Biosciences (NASDAQ:CRBU) Releases Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Caribou Biosciences Q2 EPS beats estimate, sales miss - scanx.trade
Form 8K Caribou Biosciences Inc For: 13 August By Investing.com - Investing.com Australia
Caribou Biosciences, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CARIBOU BIOSCIENCES ($CRBU) Releases Q2 2026 Earnings - Quiver Quantitative
Caribou Biosciences reports Q2 2026 results: $1.5M licensing revenue, $24.3M GAAP net loss - TradingView
Caribou Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Caribou's Single-Dose CAR-T Shows 92% Response in 12 Myeloma Patients - Stock Titan
Caribou Biosciences Inc (CRBU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Caribou Biosciences, Inc. expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Number of shareholders of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Caribou Biosciences, Inc. $CRBU Stock Holdings Raised by Renaissance Technologies LLC - MarketBeat
Spotlight On Promising Penny Stocks For August 2026 - Sahm
Caribou Biosciences (CRBU) to Announce Earnings on Wednesday - MarketBeat
CRBU Q2'26 Earnings: revenue estimate is 2.28M USD - TradingView
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - TMX Newsfile
Caribou Biosciences (CRBU) Pulls Back to $1.46 as Clinical-Stage Biotech Faces Selling PressureBox Spread - dars.gov.et
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that. - pharmavoice.com
CRBU|Caribou Biosciences Inc|Price:1.650|Chg%:+0.010 - TradingKey
CRBU|Caribou Biosciences Inc|Price:1.585|Chg%:+0.015 - TradingKey
Caribou Biosciences Inc (CRBU) Valuation: PE, PB & Fair Value Analysis - TradingKey
Caribou Biosciences Inc (CRBU) Cash Flow - TradingKey
BlackRock (NYSE: BLK) reports 7.2% beneficial stake in Caribou Biosciences (CRBU) - Stock Titan
Caribou Biosciences Inc (CRBU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Caribou Biosciences Inc (CRBU) Balance Sheet - TradingKey
Enterprise value to EBITDA forward of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Caribou Biosciences Inc (CRBU) Income Statement - TradingKey
Caribou Biosciences Inc (CRBU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Caribou Biosciences, Inc. Revenue Breakdown – NASDAQ:CRBU - TradingView
Caribou Biosciences Inc (CRBU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CRBU|Caribou Biosciences Inc|Price:1.570|Chg%:-0.060 - TradingKey
Caribou Biosciences Inc (CRBU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value to EBIT forward of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Price to earnings forward of Caribou Biosciences, Inc. – NASDAQ:CRBU - TradingView
Caribou Biosciences (NASDAQ:CRBU) Stock Price Up 1.9%Time to Buy? - MarketBeat
Caribou Biosciences secures e-poster spot for ANTLER abstract at PPLC 2026 - Traders Union
Caribou Biosciences Inc (CRBU) Institutional Confidence - TradingKey
Are medical stocks lagging Caribou Biosciences (CRBU) this year? - MSN
Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year? - Yahoo Finance
Multiple Myeloma Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Bluebird bio, Cellectis SA, Caribou Biosciences, Luminary Therapeutics, Poseida Therapeutics - Barchart.com
The Gross Law Firm Notifies Shareholders of Caribou Biosciences, - GuruFocus
Caribou Biosciences stock holds focus on CRISPR therapies - ad-hoc-news.de
Discover 3 Promising Penny Stocks With Market Caps Above $30M - simplywall.st
Caribou Biosciences, Inc.(NasdaqGS: CRBU) added to Russell 2000 Index - marketscreener.com
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Investing News Network
Caribou Biosciences, Inc.(NasdaqGS:CRBU) added to Russell Microcap Value Benchmark Index - marketscreener.com
Caribou Biosciences, Inc.(NasdaqGS: CRBU) added to Russell 2000 Value Benchmark - marketscreener.com
Caribou CEO set for fireside chat at cell therapy conference June 30 - Stock Titan
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewswire Inc.
Caribou Biosciences, Inc.(NasdaqGS: CRBU) added to Russell Microcap Index - marketscreener.com
Caribou Biosciences, Inc.(NasdaqGS:CRBU) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
CRBUCaribou Biosciences Inc Latest SEC Filings - Finviz
Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences - The National Law Review
Caribou Biosciences, Inc.(NasdaqGS:CRBU) added to Russell Small Cap Completeness Index - marketscreener.com
Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirt - The National Law Review
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):